CVS Health Co. (NYSE:CVS) Shares Sold by Signaturefd LLC

Signaturefd LLC lessened its position in shares of CVS Health Co. (NYSE:CVS) by 20.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 13,875 shares of the pharmacy operator’s stock after selling 3,511 shares during the quarter. Signaturefd LLC’s holdings in CVS Health were worth $623,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CVS. Pathstone Holdings LLC increased its stake in shares of CVS Health by 2.0% during the third quarter. Pathstone Holdings LLC now owns 222,285 shares of the pharmacy operator’s stock worth $13,977,000 after purchasing an additional 4,432 shares in the last quarter. OneAscent Financial Services LLC purchased a new stake in CVS Health during the 3rd quarter worth approximately $309,000. Meeder Asset Management Inc. raised its holdings in shares of CVS Health by 2,925.0% during the third quarter. Meeder Asset Management Inc. now owns 10,285 shares of the pharmacy operator’s stock valued at $647,000 after acquiring an additional 9,945 shares during the last quarter. Prospera Financial Services Inc boosted its stake in shares of CVS Health by 5.8% in the third quarter. Prospera Financial Services Inc now owns 34,555 shares of the pharmacy operator’s stock worth $2,174,000 after acquiring an additional 1,908 shares during the last quarter. Finally, Banque Cantonale Vaudoise increased its position in shares of CVS Health by 1.7% during the third quarter. Banque Cantonale Vaudoise now owns 36,545 shares of the pharmacy operator’s stock worth $2,298,000 after purchasing an additional 602 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Edward Jones raised shares of CVS Health from a “hold” rating to a “buy” rating in a research note on Thursday, January 30th. Leerink Partnrs raised shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 12th. TD Cowen raised their target price on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, November 25th. JPMorgan Chase & Co. boosted their target price on CVS Health from $80.00 to $81.00 and gave the stock an “overweight” rating in a report on Tuesday, February 18th. Finally, Evercore ISI lifted their price objective on CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research report on Monday, January 27th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and a consensus target price of $69.83.

Insider Transactions at CVS Health

In other news, Director Michael F. Mahoney purchased 30,000 shares of the stock in a transaction on Tuesday, February 18th. The stock was bought at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the acquisition, the director now directly owns 39,356 shares of the company’s stock, valued at approximately $2,625,045.20. The trade was a 320.65 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP James David Clark sold 7,513 shares of the firm’s stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the sale, the senior vice president now owns 8,394 shares in the company, valued at $556,941.90. The trade was a 47.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.24% of the company’s stock.

CVS Health Trading Up 0.4 %

NYSE CVS opened at $67.84 on Thursday. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75. The firm has a 50 day simple moving average of $59.76 and a 200-day simple moving average of $57.20. The firm has a market cap of $85.53 billion, a price-to-earnings ratio of 18.54, a PEG ratio of 0.98 and a beta of 0.54. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. Equities research analysts anticipate that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.92%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s payout ratio is presently 72.68%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.